Lexicon Interest Expense Trend from 2010 to 2022

LXRX
 Stock
  

USD 2.13  0.09  4.05%   

Lexicon Pharmaceutcl Interest Expense yearly trend continues to be fairly stable with very little volatility. Interest Expense is likely to outpace its year average in 2022. During the period from 2010 to 2022, Lexicon Pharmaceutcl Interest Expense regression line of anual values had slope of 682,888 and arithmetic mean of  6,868,393. Lexicon Pharmaceutcl Direct Expenses is fairly stable at the moment as compared to the past year. Lexicon Pharmaceutcl reported Direct Expenses of 1.74 Million in 2021. Cost of Revenue is likely to rise to about 2.5 M in 2022, whereas Consolidated Income is likely to drop (94.7 M) in 2022.
  
Check Lexicon Pharmaceutcl financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexicon main balance sheet or income statement drivers, such as Direct Expenses of 1.9 M, Cost of Revenue of 2.5 M or Gross Profit of 305.8 K, as well as many exotic indicators such as Interest Coverage of 7.93, Long Term Debt to Equity of 1.94 or PPandE Turnover of 0.41. Lexicon financial statements analysis is a perfect complement when working with Lexicon Pharmaceutcl Valuation or Volatility modules. It can also supplement Lexicon Pharmaceutcl's financial leverage analysis and stock options assessment as well as various Lexicon Pharmaceutcl Technical models . Additionally, see the analysis of Lexicon Pharmaceutcl Correlation against competitors.

Lexicon Interest Expense Breakdown

Showing smoothed Interest Expense of Lexicon Pharmaceutcl with missing and latest data points interpolated. Amount of the cost of borrowed funds accounted for as interest expense.Lexicon Pharmaceutcl's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexicon Pharmaceutcl's overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Increasing
Slightly volatile
   Interest Expense   
Share
       Timeline  

Lexicon Interest Expense Regression Statistics

Arithmetic Mean 6,868,393
Geometric Mean 4,039,629
Coefficient Of Variation 104.83
Mean Deviation 5,462,681
Median 2,528,000
Standard Deviation 7,199,856
Range 19,975,000
R-Value 0.37
R-Squared 0.14
Significance 0.21
Slope 682,888

Lexicon Interest Expense History

20122.1 M
2013M
20142.3 M
20156.7 M
20166.6 M
2017M
201820.8 M
201920.7 M
202014.5 M
2021802 K
2022823.1 K

About Lexicon Pharmaceutcl Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Lexicon Pharmaceutcl income statement, its balance sheet, and the statement of cash flows. Lexicon Pharmaceutcl investors use historical funamental indicators, such as Lexicon Pharmaceutcl's Interest Expense, to determine how well the company is positioned to perform in the future. Although Lexicon Pharmaceutcl investors may use each financial statement separately, they are all related. The changes in Lexicon Pharmaceutcl's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Lexicon Pharmaceutcl's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Lexicon Pharmaceutcl Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Lexicon Pharmaceutcl. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Interest Expense802 K823.1 K
Earnings Before Interest Taxes and Depreciation Amortization EBITDA-86.7 M-93.6 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Lexicon Pharmaceutcl without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Premium Stories Now

   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Lexicon Pharmaceutcl using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see the analysis of Lexicon Pharmaceutcl Correlation against competitors. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for analysis

When running Lexicon Pharmaceutcl price analysis, check to measure Lexicon Pharmaceutcl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceutcl is operating at the current time. Most of Lexicon Pharmaceutcl's value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceutcl's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lexicon Pharmaceutcl's price. Additionally, you may evaluate how the addition of Lexicon Pharmaceutcl to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Is Lexicon Pharmaceutcl's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexicon Pharmaceutcl. If investors know Lexicon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexicon Pharmaceutcl listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.63) 
Market Capitalization
402 M
Quarterly Revenue Growth YOY
0.7
Return On Assets
(0.33) 
Return On Equity
(0.69) 
The market value of Lexicon Pharmaceutcl is measured differently than its book value, which is the value of Lexicon that is recorded on the company's balance sheet. Investors also form their own opinion of Lexicon Pharmaceutcl's value that differs from its market value or its book value, called intrinsic value, which is Lexicon Pharmaceutcl's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexicon Pharmaceutcl's market value can be influenced by many factors that don't directly affect Lexicon Pharmaceutcl's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexicon Pharmaceutcl's value and its price as these two are different measures arrived at by different means. Investors typically determine Lexicon Pharmaceutcl value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexicon Pharmaceutcl's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.